1h Free Analyst Time
The peptide therapeutics market is forecasted to grow by USD 17.85 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the peptide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, availability of favorable reimbursement policies, and drugs with extended half-life.
The peptide therapeutics market is segmented as below:
By Route Of Administration
- Parenteral
- Oral
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the peptide therapeutics market covers the following areas:
- Peptide therapeutics market sizing
- Peptide therapeutics market forecast
- Peptide therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global peptide therapeutics market: Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is collaborations for r and d."
According to the report, one of the major drivers for this market is the increasing prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Almac Group Ltd.
- AmbioPharm Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bachem AG
- Bristol Myers Squibb Co.
- Corden Pharma International GmbH
- Eli Lilly and Co.
- Ever Pharma
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Ipsen Pharma
- Lonza Group Ltd.
- Novartis AG
- Novo Nordisk AS
- PeptiDream Inc.
- Pfizer Inc.
- PolyPeptide Group
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Worg pharma
